Annual EBITDA
-$122.51 M
-$3.35 M-2.81%
December 31, 2023
Summary
- As of February 22, 2025, TNYA annual EBITDA is -$122.51 million, with the most recent change of -$3.35 million (-2.81%) on December 31, 2023.
- During the last 3 years, TNYA annual EBITDA has fallen by -$86.08 million (-236.29%).
- TNYA annual EBITDA is now -376.25% below its all-time high of -$25.72 million, reached on December 31, 2019.
Performance
TNYA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$24.61 M
+$4.09 M+14.25%
September 30, 2024
Summary
- As of February 22, 2025, TNYA quarterly EBITDA is -$24.61 million, with the most recent change of +$4.09 million (+14.25%) on September 30, 2024.
- Over the past year, TNYA quarterly EBITDA has increased by +$4.13 million (+14.37%).
- TNYA quarterly EBITDA is now -197.87% below its all-time high of -$8.26 million, reached on June 1, 2020.
Performance
TNYA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$114.18 M
+$4.13 M+3.49%
September 30, 2024
Summary
- As of February 22, 2025, TNYA TTM EBITDA is -$114.18 million, with the most recent change of +$4.13 million (+3.49%) on September 30, 2024.
- Over the past year, TNYA TTM EBITDA has increased by +$11.49 million (+9.14%).
- TNYA TTM EBITDA is now -1215.16% below its all-time high of -$8.68 million, reached on March 31, 2020.
Performance
TNYA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TNYA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.8% | +14.4% | +9.1% |
| 3 y3 years | -236.3% | +14.4% | +9.1% |
| 5 y5 years | -376.3% | +14.4% | +9.1% |
TNYA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -75.4% | at low | at high | +25.2% | -63.5% | +9.5% |
| 5 y | 5-year | -376.3% | at low | -197.9% | +25.2% | -1215.2% | +9.5% |
| alltime | all time | -376.3% | at low | -197.9% | +25.2% | -1215.2% | +9.5% |
Tenaya Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.61 M(-14.3%) | -$114.18 M(-3.5%) |
| Jun 2024 | - | -$28.70 M(-9.2%) | -$118.31 M(-3.4%) |
| Mar 2024 | - | -$31.61 M(+8.0%) | -$122.52 M(+0.0%) |
| Dec 2023 | -$122.51 M(+2.8%) | -$29.27 M(+1.8%) | -$122.51 M(-2.5%) |
| Sep 2023 | - | -$28.74 M(-12.7%) | -$125.67 M(-0.4%) |
| Jun 2023 | - | -$32.91 M(+4.2%) | -$126.15 M(+4.6%) |
| Mar 2023 | - | -$31.59 M(-2.6%) | -$120.56 M(+1.2%) |
| Dec 2022 | -$119.15 M | -$32.43 M(+11.0%) | -$119.15 M(+6.3%) |
| Sep 2022 | - | -$29.21 M(+6.9%) | -$112.09 M(+11.6%) |
| Jun 2022 | - | -$27.32 M(-9.5%) | -$100.44 M(+14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$30.19 M(+19.0%) | -$87.62 M(+25.4%) |
| Dec 2021 | -$69.84 M(+91.7%) | -$25.37 M(+44.5%) | -$69.84 M(+29.0%) |
| Sep 2021 | - | -$17.55 M(+21.0%) | -$54.14 M(+16.7%) |
| Jun 2021 | - | -$14.50 M(+16.8%) | -$46.40 M(+15.5%) |
| Mar 2021 | - | -$12.42 M(+28.5%) | -$40.16 M(+10.3%) |
| Dec 2020 | -$36.43 M(+41.6%) | - | - |
| Dec 2020 | - | -$9.66 M(-1.6%) | -$36.43 M(+36.1%) |
| Sep 2020 | - | -$9.82 M(+18.9%) | -$26.77 M(+58.0%) |
| Jun 2020 | - | -$8.26 M(-4.8%) | -$16.94 M(+95.2%) |
| Mar 2020 | - | -$8.68 M | -$8.68 M |
| Dec 2019 | -$25.72 M | - | - |
FAQ
- What is Tenaya Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Tenaya Therapeutics?
- What is Tenaya Therapeutics annual EBITDA year-on-year change?
- What is Tenaya Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Tenaya Therapeutics?
- What is Tenaya Therapeutics quarterly EBITDA year-on-year change?
- What is Tenaya Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Tenaya Therapeutics?
- What is Tenaya Therapeutics TTM EBITDA year-on-year change?
What is Tenaya Therapeutics annual EBITDA?
The current annual EBITDA of TNYA is -$122.51 M
What is the all time high annual EBITDA for Tenaya Therapeutics?
Tenaya Therapeutics all-time high annual EBITDA is -$25.72 M
What is Tenaya Therapeutics annual EBITDA year-on-year change?
Over the past year, TNYA annual EBITDA has changed by -$3.35 M (-2.81%)
What is Tenaya Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TNYA is -$24.61 M
What is the all time high quarterly EBITDA for Tenaya Therapeutics?
Tenaya Therapeutics all-time high quarterly EBITDA is -$8.26 M
What is Tenaya Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TNYA quarterly EBITDA has changed by +$4.13 M (+14.37%)
What is Tenaya Therapeutics TTM EBITDA?
The current TTM EBITDA of TNYA is -$114.18 M
What is the all time high TTM EBITDA for Tenaya Therapeutics?
Tenaya Therapeutics all-time high TTM EBITDA is -$8.68 M
What is Tenaya Therapeutics TTM EBITDA year-on-year change?
Over the past year, TNYA TTM EBITDA has changed by +$11.49 M (+9.14%)